Predicting heart failure mortality in frail seniors: Comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0

International Journal of Cardiology

Volumn 155, Issue 1, 2012, Pages 75-80

  Tjam, Erin Y ^a,b   Heckman, George A ^b   Smith, Stuart ^a   Arai, Bruce ^c   Hirdes, John ^b,d   Poss, Jeff ^b   McKelvie, Robert S ^e,f  

^a St Mary's General Hospital   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c WILFRID LAURIER UNIVERSITY   (Canada)

^d HOMEWOOD RESEARCH INSTITUTE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f HHS   (Canada)

Author keywords

Frailty; Heart failure; InterRAI; Minimum data set; Mortality; NYHA; Resident assessment instrument

Indexed keywords

ADL DISABILITY; ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CHANGES IN HEALTH END STAGE DISEASE SIGNS AND SYMPTOMS SCALE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DECREASED APPETITE; DISEASE ASSOCIATION; FEMALE; FRAIL ELDERLY; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MORTALITY; NEW YORK HEART ASSOCIATION FUNCTIONAL ASSESSMENT; NONBIOLOGICAL MODEL; NURSING HOME PATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RELIABILITY; RESIDENT ASSESSMENT INSTRUMENT; SECONDARY ANALYSIS; WEIGHT GAIN;

EID: 84859923256     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.01.031     Document Type: Article

References (48)

1. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci 2001;65A:M88-96.
2. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005;366:1578-82.
3. Bleumink GS, Knetsch AM, Sturkenboom MCJM, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J 2004;25:1614-9.
4. Butler R, Fonseka S, Barclay L, Sembhi S, Wells S. The health of elderly residents in long term care institutions in New Zealand. NZ Med J 1999;112:427-9.
5. Lee DS, Johansen H, Gong Y, Hall RE, Tu JV, Cox JL. Regional outcomes of heart failure in Canada. Can J Cardiol 2004;20:599-607.
6. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006 Jan;22(1):23-45.
7. Rouleau JL. Treatment of congestive heart failure: present and future. Can J Cardiol 2005;21(12):1084-8.
8. Heckman GA, Demers C, McKelvie RS, Hogan DB. Heart failure in older adults. Can J Intern Med 2007;2:24-6.
9. Smith ER. A special issue on chronic heart failure. Can J Cardiol 2003;19(4):345-6.
10. Wilson E. Congestive heart failure: a national priority. Can J Cardiol 2001;17(2): 1243-6.
11. Johansen H, Strauss B, Arnold JM, Moe G, Liu P. On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol Mar 31 2003;19(4):430-5.
12. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients with newly hospitalized heart failure. Arch Intern Med 2002;162: 1689-94.
13. Huynh BC, Rovner A, Rich MW. Long-term survival in elderly patients hospitalized for heart failure. Arch Intern Med 2006;166:1892-8.
14. Nomenclature and criteria for diagnosis of the heart and great vessels. 9th ed. Boston (MA): Little, Brown, & Co; 1994. p. 253-6.
15. Bennett JA, Riegel B, Bittner V, Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 2002;31:262-70.
16. Raphael C, Briscoe C, Davies J, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007;93:476-82.
17. Gibelin P. An evaluation of symptom classification systems used for the assessment of patients with heart failure in France. Eur J Heart Fail 2001;3: 739-46.
18. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981;64:1227-34.
19. Hirdes JP. Addressing the health needs of frail elderly people: Ontario's experience with an integrated health information system. Age Ageing 2006;35:329-31.
20. Poss JW, Jutan NM, Hirdes JP, et al. A review of evidence on the reliability and validity of MDS data. Healthc Manage Forum 2008;21:31-7.
21. Hirdes JP, Fries BE, Morris JN, et al. Integrated health information systems based on the RAI/MDS series of instruments. Healthc Manage Forum 1999;12:30-40.
22. Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS Scale: a new measure to predict mortality in institutionalized older people. J Am Geriatr Soc 2003;51:96-100.
23. Armstrong JJ, Stolee P, Hirdes JP, Poss JW. Examining three frailty conceptualizations in their ability to predict negative outcomes for home-care clients. Age Ageing 2010;39:755-8.
24. Wang R, Mouliswar M, Denman S, Kleban M. Mortality of the institutionalized old-old hospitalized with congestive heart failure. Arch Intern Med 1998;158: 2464-8.
25. Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med 1995;155:1060-4.
26. Inouye SK. Delirium in older persons. N Engl J Med 2006;354:1157-65.
27. Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008;69:889-98.
28. Heckman GA, Patterson CG, Demers C, St-Onge J, Turpie ID, McKelvie RS. Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging 2007;2:209-18.
29. Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging 2000;17:353-62.
30. Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34:427-32.
31. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-11.
32. Domanski M, Fleg J, Bristow M, Knox S. The effect of gender on outcome in digitalis-treated heart failure patients. J Card Fail 2005;11:83-6.
33. Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing 2005;34:218-27.
34. Gustafsson F, Schou M, Videbaek L, et al. Danish Heart Failure Clinics Network. Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics. Eur J Heart Fail 2009;11:413-9.
35. Remes J, Miettinen H, Reuanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
36. Tjam EY, Pletz DE, Hirdes JP, et al. Prevention of avoidable acute care use by retirement and long term care residents: management of chronic heart failure through the use of an innovative inter-disciplinary education program for care providers (EPOCH study). Vancouver, BC: Presented at the Canadian Cardiovascular Society; October 2006.
37. Fahey CJ. In: Weiner AS, Ronch JL, editors. Culture change in long-term care facilities: changing the facility or changing the system? Culture change in longterm careBinghamton NY: Haworth Press; 2003.
38. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. JAMA 1963;185:914-9.
39. Heckman GA, Misiaszek B, Merali F, et al. The management of heart failure in Canadian long-term care facilities. Can J Cardiol 2004;20:963-9.
40. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemilogy, clinical characteristics, and prognosis. J Am Coll Cardiol 2004;43:317-27.
41. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
42. Lenzen MJ, Scholte op Reimer WJ, Boersma E, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-21.
43. Ceia F, Fonesca C, Mota T, et al. Prevalence of chronic heart failure in southwestern Europe: the EPICA Study. Eur J Heart Fail 2002;4:531-9.
44. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
45. Wodchis WP, Naglie G, Teare GF. Validating the diagnostic information on the minimum data set in Ontario hospital-based long-term care. Med Care 2008;46: 882-7.
46. Gray LC, Berg K, Fries BE. Sharing clinical information across care settings: the birth of an integrated assessment system. BMC Health Serv Res 2009;29:71.
47. Hirdes JP, Ljunggren G, Morris JN, et al. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res 2008;30:277.
48. Shewan LG and Coats AJ. Ethics in the authorship and publishing of scientific articles Int J Cardiol 2010;144:1-2.